MIR9-3 and neoplasm: We identified MIR182, MIR183, MIR371, MIR373, MIR512-1, MIR512-2, MIR515-1, and MIR520e exhibiting high expression and MIR216b, MIR887, MIR9-2, and MIR9-3 exhibiting low expression in NANOG H/L tumours (Fig. 2D).